Dcgi Singh

Rediff.com » News » Dcgi Singh

News for Dcgi Singh

News
Business

Govt launches all India drive to test cough syrups

Central drug regulator Central Drugs Standard Control Organisation (CDSCO) has started a pan India drive to test, inspect and audit cough syrup manufacturers, official sources said on Thursday.......

DCGI approves market authorisation for Covovax as Covid booster dose

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or......

Serum Institute seeks DCGI nod for Covovax

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to manufacture COVID-19 vaccine Covovax for restricted use in emergency situations at its......

DCGI approves Covovax for emergency use in 12-17 yrs age group

India's drug regulator has granted restricted emergency use authorisation to Serum Institute's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions. IMAGE: A......

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

The Drugs Controller General of India on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use......

Quality Lapses Shut Down Drug Makers

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories. IMAGE: Kindly note the image has been posted only......

As drug firms squirm, authorities look abroad for cure

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices Even as the domestic pharmaceutical industry feels the heat of global scrutiny, the Drugs......

Are Ranbaxy drugs available in India safe?

At a time India-made medicines appear to be losing sheen the world over, the country’s top regulator, the Drug Controller General of India (DCGI), is struggling to ensure quality of drugs in......

Why is Novartis likely to lose Tiamulin drug licence?

Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin Hydrogen Fumarate (80 per cent granules) in India.......

Regulator might inspect Wockhardt units

After Ranbaxy, another major domestic drug maker is likely to come under the scanner of the Indian drug regulator. As a proactive measure to ensure quality and compliance, the government might......

Dcgi Singh

News for Dcgi Singh

Govt launches all India drive to test cough syrups

DCGI approves market authorisation for Covovax as Covid booster dose

Serum Institute seeks DCGI nod for Covovax

DCGI approves Covovax for emergency use in 12-17 yrs age group

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

Quality Lapses Shut Down Drug Makers

As drug firms squirm, authorities look abroad for cure

Are Ranbaxy drugs available in India safe?

Why is Novartis likely to lose Tiamulin drug licence?

Regulator might inspect Wockhardt units

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS